University of Oulu

Salem A and Salo T (2020) Commentary: Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications. Front. Pharmacol. 11:874. doi: 10.3389/fphar.2020.00874

Commentary : pathophysiological role of histamine H4 receptor in cancer : therapeutic implications

Saved in:
Author: Salem, Abdelhakim1,2; Salo, Tuula1,2,3,4
Organizations: 1Department of Oral and Maxillofacial Diseases, Clinicum, University of Helsinki, Helsinki, Finland
2Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland
3Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland
4Department of Oral Pathology, Helsinki University Hospital (HUS), Helsinki, Finland
Format: article
Version: published version
Access: open
Online Access: PDF Full Text (PDF, 0.5 MB)
Persistent link:
Language: English
Published: Frontiers Media, 2020
Publish Date: 2020-09-10
Series: Frontiers in pharmacology
ISSN: 1663-9812
ISSN-E: 1663-9812
ISSN-L: 1663-9812
Volume: 11
Pages: 1 - 3
Article number: 874
DOI: 10.3389/fphar.2020.00874
Type of Publication: A1 Journal article – refereed
Field of Science: 3122 Cancers
Funding: This work was supported by Emil Aaltonen Foundation (Emil Aaltosen Säätiö); The Maud Kuistila Memorial Foundation; The Jane and Aatos Erkko Foundation; and Helsinki University Central Hospital (HUS) Research Funds.
Copyright information: © 2020 Salem and Salo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.